Clinician Scientist and Professor of Paediatric Haematology at University of Oxford. Developmental haematopoiesis and leukaemia
Joined March 2009
- Tweets2.4K
- Following783
- Followers1.5K
- Likes6.4K
andi roy retweeted
🔬🧬 come hang out with me for a bit (2 PhD opportunities)👇 @UofGlasgow @UofGMVLS
findaphd.com/phds/project/fu…
findaphd.com/phds/project/fu…
andi roy retweeted
Becoming a parent is much more detrimental to women’s academic careers than it is to men’s
Read the full story: go.nature.com/4v0XLiz
andi roy retweeted
We're hiring a new 3 yr postdoc!
Come join us at @SussexUni for exciting new @CR_UK funded project targeting RUNX1 mutations in CML in a highly supportive research environment within @Sussex_BCR @SussexLifeSci @BiochemBiomedUS @Sussex_Cancer
Apply 👇, advert closes 8th March.
New post: Research Fellow in Biochemistry & Biomedicine (Fixed Term)
Ref: 43139
Closing Date: 08 March 2026
To apply visit: jobs.sussex.ac.uk/job/4fee4e…
andi roy retweeted
We are looking for a new 👩🔬lab member🧑🔬 to join our team @StAnna_CCRI and @CeMM_News and work with 🐭🩸in vivo models of leukemia. 🐭🩸
👇👇
ccri.at/working-at-the-ccri/…
seruggialab.com/gallery/
andi roy retweeted
£1 won’t change your day, but it could change a child’s life 🧡
Don’t scroll past childhood cancer.
Give £1 today. donorbox.org/1-campaign-9001…
🧡🦁
andi roy retweeted
Very pleased to share our latest pre-print which showcases the incredible hard work and skill of Dr @oknsvm.
Our continued exploration of β-catenin's contribution to the post transcriptional landscape of blood cells led us to a LIN28B interaction.
1/7
biorxiv.org/content/10.64898…
andi roy retweeted
Patient-specific enhancers in genetically uniform leukemias ow.ly/qWnn50Xh8Ff #lymphoidneoplasia
andi roy retweeted
New in @BloodPortfolio! 🩸
Researchers with Dr. Karadimitris equip iNKT with CD19- and/or CD133-targeting CARs and investigate their anti-#leukemia activity against KMT2A-rearranged acute lymphoblastic leukemia in vivo and in vitro. 🧫
bit.ly/47vYIX8
andi roy retweeted
NEWS: New ‘off-the-shelf’ immunotherapy shows promise for treating high-risk childhood leukaemia
Scientists have found that a modified therapy called CAR-iNKT is highly efficient when compared with standard CAR-T therapy.
ow.ly/Su8650WQpRX
andi roy retweeted
Pleased that the 2nd part of my PhD in now available as a preprint! Here, we investigated the epigenomic and transcriptomic changes occurring upon PRC2 depletion in AML cells. biorxiv.org/content/10.1101/…. A thread🧵1/17
andi roy retweeted
A modified CAR-iNKT therapy that targets two markers (CD19 + CD133) eliminated a high-risk childhood leukaemia in mice, outperforming standard CAR-T therapy. 💉
This is a step toward more efficient treatments for children with leukaemia.❤️🩹
imperial.ac.uk/news/268073/m…
andi roy retweeted
This is such great news for Leukaemia Research and our group led by @andiroy at the start of #bloodcancerawareness month
NEW: The Kaiya Foundation has awarded a grant to Dr Emily Neil and Prof Anindita Roy (Childhood Leukaemia Research Group) to help transform the treatment of high-risk leukaemia through personalised medicine.
Read more from @OxPaediatrics ⬇️
ALT An aerial view of the University of Oxford, featuring the prominent dome of the Radcliffe Camera, with the headline: The Kaiya Foundation to fund leukaemia research at University of Oxford
andi roy retweeted
NEW: The Kaiya Foundation has awarded a grant to Dr Emily Neil and Prof Anindita Roy (Childhood Leukaemia Research Group) to help transform the treatment of high-risk leukaemia through personalised medicine.
Read more from @OxPaediatrics ⬇️
ALT An aerial view of the University of Oxford, featuring the prominent dome of the Radcliffe Camera, with the headline: The Kaiya Foundation to fund leukaemia research at University of Oxford
andi roy retweeted
Are you a parent whose child is undergoing/has previously had treatment for cancer? We welcome you to join our infant leukaemia study team (cancer.ox.ac.uk/research/SAI…) to help develop a parent reported outcome questionnaire. Details of how to join/contact us below. Please share.
andi roy retweeted
Various types of leukemia share a hematopoietic stem and progenitor population (HSPC-like) associated with chemoresistance and poor outcome. ow.ly/C6xm50W5ffH #hematopoiesisandstemcells #lymphoidneoplasia #myeloidneoplasia #pediatrichematology
andi roy retweeted
Join me and Dr David Palmer, Haematology Clinician at @UHSussex @BSMSMedSchool, for a 3.5 year @SussexLifeSci funded PhD (UK home fees only) studying RUNX1 mutations in myeloid leukaemia here at @SussexUni @Sussex_BCR @Sussex_Cancer
Details and apply👇👇
sussex.ac.uk/study/fees-fund…
andi roy retweeted
📢 We've updated our free resource for children, 'My brother or sister has cancer,' to help siblings cope with a cancer diagnosis. We encourage HCPs to share this resource with families and suggest that parents read it with their child at bit.ly/4k7C1vR #CYPCancer
andi roy retweeted
We're hiring! Join our team at Oxford to work on cutting-edge research in haematology and myeloproliferative neoplasms.
Apply here 👉 my.corehr.com/pls/uoxrecruit…
Learn more about our work 👉 imm.ox.ac.uk/research/resear…
@Ludwig_Cancer @MRC_WIMM
#AcademicJobs #Haematology #MPN #Oxford
andi roy retweeted
We're excited to launch our brand-new #EarlyCareerResearcher Network, open to CCLG member researchers in the early stages of their involvement with children and young people's cancer research ✨🔬
Express your interest in joining: bit.ly/43eE3mv
#CYPCancer
